Introduction
Breast cancer is the most common form of cancer in women in the UK, accounting for 30% of all new cases [1] . Women with a family history of breast cancer are at an increased risk of developing this disease. Recent scientifi c breakthroughs in medical genetics and growing public awareness have led to a greater demand for advice and increased referrals to familial cancer clinics [2] . In addition to risk assessment, women want information about ways to prevent or minimize the chance of developing breast cancer [3] . While many are indeed at signifi cantly increased risk of developing breast cancer, 23-40% of all women referred to breast cancer family clinics are considered (on the basis of their family history) to be at relatively low genetic risk [4] [5] [6] [7] . These women are not generally offered access to special surveillance services. The aim of this paper is to report on a survey of generic risk status letters and printed materials (in the form of leafl ets) provided to this category of counselees by UK cancer genetics centres.
Society of Human Genetics was followed up by a letter sent directly by the authors. Overall, 20 centres replied, and from 16 of these, generic letters and/or printed materials were received. Four centres stated that they rarely or never receive 'low-risk' referrals. We also consulted the UK National Institute for Clinical Excellence (NICE) guidelines [5] , the Scottish Intercollegiate Guidelines Network (SIGN) guidelines [6] , the American Cancer Society [8] , and the Australian National Health and Medical Research Council [9] and National Breast Cancer Centre [10] on the population incidence of breast cancer. All leafl ets and letters were read and their content was analysed by G.O. Specifi cally, the quoted levels of risk were collated and contextual details noted. Ambiguous features of the written information were discussed by all authors to derive consensus.
Results
Two sets of observations ( table 1 ) on the printed material and generic letters were recorded.
Breast Cancer Incidence Information. The overall (population) breast cancer cumulative incidence cited in the risk status letters and leafl ets ranged from '1 in 9' to '1 in 12' women ( fi g. 1 ). In the case of 1 centre, although the letter stated the population risk level as '1 in 9', the CancerBACUP leafl et that they provided as an accompaniment quoted a level of '1 in 10'. Of the 13 centres which provided cumulative incidence information, 8 stated a 'lifetime risk', 2 stated the risk as either 'by the time the woman is 80' or for 'women under 80', while 3 centres did not specify any age range.
The NICE guidelines state the cumulative incidence as '1 in 10' by the age of 80, SIGN as 8% by the age of 74. The American Cancer Society reports the lifetime incidence in the United States as about '1 in 7' [8] , whereas the Australian National Health and Medical Research Council [9] gives a level of '1 in 11' and the National Breast Cancer Centre in Australia [10] '1 in12' before the age of 75.
Delivery of Risk Assessment. The main theme was the message that the personal risk of developing breast cancer was not signifi cantly raised above that of anyone else in the general population. Statements used included: 'If you are at low risk, your chances of getting breast cancer are not much different from that of any other woman in the population.' 'On the basis of your family history you are not at a signifi cantly increased risk of developing cancer yourself.' 'I would like to reassure you that your family history of breast cancer does not signifi cantly increase your own risk of the disease. This is a low risk family history.' 'This means that your chances of developing breast cancer during your lifetime are no different from the chances of any other individual in the population.' 
Discussion
The effective provision of cancer risk information is important for the comprehension and retention of complex information that is valuable both to the patients and their close relatives. A lack of consensus on how to communicate health risk information effectively [11] presents challenges for health care professionals who are faced with ever increasing numbers of patients seeking advice about personal health risks such as breast cancer. Patients at the lower end of the risk spectrum for hereditary forms of breast cancer comprise a large portion of all referrals to breast cancer family clinics. These patients, after receiving risk information based on their family history, are usually discharged from the services until they reach 50 years of age, when they are entitled to participate in the National Breast Screening Programme, although, in fact, their risks may be appreciably higher than those quoted for the general population [12] . It can be argued that the term 'low' (or 'lower') risk, frequently used as 'shorthand' by the familial cancer clinics and even in some authoritative literature (though not by the NICE or SIGN guidelines), is misleading and may potentially contribute to inaccurate perceptions of risk of developing breast cancer.
The observed diversity in the fi gures quoted can be confusing for patients and their relatives who may derive cancer-related information from different sources and compare notes. Such apparent discrepancies are understandable given that breast cancer risk is highly probabilistic, that the cumulative incidence of the disease varies from country to country and that there are different (valid) methods of calculating risk. Cumulative incidence rates can be calculated on the basis of past cohorts (i.e. historical rates based on those who have completed a full life). The actual lifetime risk of breast cancer was lower for those since breast cancer incidence has increased over the years in all developed countries. Alternatively, the rate may be predicted for women currently in their 30s by projecting epidemiological trends -probably a more accurate method but dependent on incomplete data. In addition, it is rarely explicit whether the fi gures cited include any cases of ductal carcinoma in situ. Greater numbers of ductal carcinoma in situ have been detected since the introduction of large-scale mammographic screening; therefore, incidence rates including these fi gures may be infl ated [13] .
Delivering information about ways to reduce breast cancer risk is also important for low-risk patients, particularly for those who are below the age of 50. This group will not be seen by specialist breast or genetics services unless they present with symptoms to their general practitioners or their family history of cancer changes. Given that health care provider recommendation is one of the most signifi cant predictors of cancer screening (e.g., breast, colorectal [14] [15] [16] ), advice and information given to them at the point of personal risk assessment (i.e. via the familial cancer clinics) may be highly salient in initiating behavioural change to reduce breast cancer risk. We observed that several of the centres included advice on risk reduction (e.g., by diet and exercise), 'breast awareness', and/or participation in the National Breast Cancer Screening Programme from age 50, but no consistent approach was adopted.
Overall, this exercise of examining generic letters and printed material emphasizes the need for agreement on more standardized and comprehensive information provision to 'low-risk' patients. This may help to reduce misunderstanding and unnecessary anxiety among patients, to improve compliance with risk-reducing measures, and to sustain confi dence in genetic and other advice offered by breast cancer family clinics.
